ZIAGEN

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ZIAGEN contains one active pharmaceutical ingredient (API):

1 Abacavir UNII J220T4J9Q2 - ABACAVIR SULFATE

Abacavir is a NRTI. It is a potent selective inhibitor of HIV-1 and HIV-2. Abacavir is metabolised intracellularly to the active moiety, carbovir 5'-triphosphate (TP). In vitro studies have demonstrated that its mechanism of action in relation to HIV is inhibition of the HIV reverse transcriptase enzyme, an event which results in chain termination and interruption of the viral replication cycle. Read about Abacavir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZIAGEN Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC
ZIAGEN Oral solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AF06	Abacavir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10294T, 10356C
Country: CA	Health Products and Food Branch	Identifier(s): 02240357, 02240358
Country: EE	Ravimiamet	Identifier(s): 1196119, 1196120
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 99112001, 99112002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 101995, 102006
Country: FR	Base de données publique des médicaments	Identifier(s): 62070450, 68556562
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44427, 44430
Country: HK	Department of Health Drug Office	Identifier(s): 46236, 63701
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4210
Country: IT	Agenzia del Farmaco	Identifier(s): 034499018, 034499020
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250014F1036
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006256, 1006257
Country: NL	Z-Index G-Standaard	Identifier(s): 14255782
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 135992, 136018
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8479, 8480
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100095210, 100095227
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65271001, W65272001
Country: SG	Health Sciences Authority	Identifier(s): 11098P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 23013041H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522096107
Country: US	FDA, National Drug Code	Identifier(s): 49702-221, 49702-222
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/20.2.8/0464, 33/20.2.8/0465